Al Altomari
2018
In 2018, Al Altomari earned a total compensation of $1.5M as Chairman & Chief Executive Officer at Agile Therapeutics, a 51% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $149,550 |
| Option Awards | $630,440 |
| Salary | $494,400 |
| Stock Awards | $122,186 |
| Other | $23,305 |
| Total | $1,519,881 |
Altomari received $630.4K in option awards, accounting for 41% of the total pay in 2018.
Altomari also received $100K in bonus, $149.6K in non-equity incentive plan, $494.4K in salary, $122.2K in stock awards and $23.3K in other compensation.
Rankings
In 2018, Al Altomari's compensation ranked 7,095th out of 14,244 executives tracked by ExecPay. In other words, Altomari earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,095 out of 14,244 | 50th |
Division Manufacturing | 2,727 out of 5,759 | 53rd |
Major group Chemicals And Allied Products | 1,028 out of 2,122 | 52nd |
Industry group Drugs | 867 out of 1,811 | 52nd |
Industry Pharmaceutical Preparations | 677 out of 1,385 | 51st |
Source: SEC filing on April 25, 2019.
Altomari's colleagues
We found two more compensation records of executives who worked with Al Altomari at Agile Therapeutics in 2018.